Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC

Clinical trial NCT06228404 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06228404
Sponsor: Shanghai Changzheng Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Castration-resistant Prostate Cancer

Start date: 2024-03-03
Primary completion: 2026-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.